Showing results (101-110 of 382) with videos related to

Sort By:
Pageof 39
Frontiers in Immunology|February 27, 2025
Advanced disease and CD8+ TEMRA cells predict severe infections in multiple myelomaEva Tranter, David Busch, Clarissa Heck, et al.
Frontiers in Oncology|January 22, 2025
Real-world experience with TTFields in glioma patients with emphasis on therapy usageClaudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, et al.
Cell Stem Cell|April 10, 2012
Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CMLFlorian H Heidel, Lars Bullinger, Zhaohui Feng, et al.
The Journal of Gene Medicine|January 10, 2012
CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination modelTam Nguyen-Hoai, Gerd Baldenhofer, Mona Sayed Ahmed, et al.
British Journal of Haematology|January 13, 2010
KIT mutations confer a distinct gene expression signature in core binding factor leukaemiaSonja C Lück, Annika C Russ, Juan Du, et al.
Epigenetics|June 17, 2016
Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networksFrank G Rücker, Katharina M Lang, Markus Fütterer, et al.
Clinical Epigenetics|October 27, 2023
Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimenMaximilian Schmutz, Manuela Zucknick, Richard F Schlenk, et al.
International Journal of Cancer|September 23, 2014
Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κBAnne Flörcken, Michael Grau, Annette Wolf, et al.
World Journal of Urology|April 23, 2011
Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitorsSteffen Weikert, Carsten Kempkensteffen, Jonas Busch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2018
CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple MyelomaJulia Bluhm, Elisa Kieback, Stephen F Marino, et al.
Pageof 39